Haleon (HLN) Long-Term Debt Issuances (2021 - 2023)
Haleon (HLN) posted Long-Term Debt Issuances of $193.6 million for Q4 2023, down 98.21% on a QoQ basis from $10.8 billion in Q4 2022, and down 98.21% year-over-year from $10.8 billion in Q4 2022.
Haleon (HLN) Long-Term Debt Issuances (2021 - 2023) Analysis & Trends
Haleon's Long-Term Debt Issuances history runs 3 years deep, the most recent figure standing at $193.6 million for Q4 2023.
- Quarterly Long-Term Debt Issuances fell 98.21% year-over-year to $193.6 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $22.4 billion (changed N/A YoY) and the FY2025 annual result came in at $60.7 million, down 96.09% from the prior year.
- Long-Term Debt Issuances was $193.6 million for Q4 2023 at Haleon, down from $10.8 billion in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $11.4 billion in Q3 2022 and bottomed at $1.3 million in Q4 2021.
- A 3-year average of $5.6 billion and a median of $5.5 billion in 2022 frame the typical range for Long-Term Debt Issuances.
- Annual changes were most pronounced in 2022 — Long-Term Debt Issuances jumped 803976.06% — and 2023, when it plunged 98.21%.
- Haleon's Long-Term Debt Issuances stood at $1.3 million in 2021, then jumped by 803976.06% to $10.8 billion in 2022, then plunged by 98.21% to $193.6 million in 2023.
- Business Quant data shows HLN's Long-Term Debt Issuances at $193.6 million in Q4 2023, $10.8 billion in Q4 2022, and $11.4 billion in Q3 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | 3.64 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.53 Bn | 10.38 Bn | 59.30 Mn | 4.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 193.62 Mn |
| Dec 31, 2023 | 193.62 Mn |
| Dec 31, 2022 | 10.84 Bn |
| Dec 31, 2022 | 10.84 Bn |
| Sep 20, 2022 | 11.38 Bn |
| Sep 20, 2022 | 11.38 Bn |
| Dec 31, 2021 | 1.35 Mn |
| Dec 31, 2021 | 1.35 Mn |